PrimeRFP SCOUT · Federal Contract Recompete Brief

15F06726F0000234GSK vaccines TERMS and conditions REMAIN — Glaxosmithkline LLC

Glaxosmithkline LLC holds $3.0B across 194 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 15F06722A0000187. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2026 PoP end — agencies typically plan 12–18 months ahead.

Division 1200

Awarding office

Glaxosmithkline LLC

Recipient

Dec 31, 2026

PoP end

$25K

Obligated

$105K

Potential

325412

NAICS

6515

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Glaxosmithkline LLC — $90

Contract facts

NONE

Contract number15F06726F0000234

Also listed as15F06722A0000187-15F06726F0000234

AgencyDivision 1200

Awarding officeDivision 1200

Awarding agencyDepartment of Justice (DOJ)

Funding agencyDepartment of Justice (DOJ)

IncumbentGlaxosmithkline LLC

CAGE667E9

UEIFRHTPHMZMX47

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDV15F06722A0000187

Place of performanceDURHAM NC

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startFeb 27, 2026

PoP end (current)Dec 31, 2026

Obligated$25K

Current value$105K

Potential value$105K

GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187 is a federal NONE award for Division 1200 held by Glaxosmithkline LLC. Estimated value $105K ($25K obligated). Current period of performance ends Dec 31, 2026. Last award drew 1 bidder. Place of performance: DURHAM NC.

GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187

Recompete timing

Public

● Expiring in 132 days

Current PoP ends Dec 31, 2026 (132 days remaining). Agencies typically plan 12–18 months ahead — at 4.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Glaxosmithkline LLC — $3.0B obligated across 194 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.0B) · all agencies

Department of Health and Human Services (HHS)$3.0B · 100%Department of Defense (DOD)$1.7M · 0%Department of Veterans Affairs (VA)$1.5M · 0%Department of State (DOS)$1.2M · 0%

Open full company profile →

Related awards

Same parent · incumbent

75A50125F61019

FILL/FINISH DOD AS03 ADJUVANT CLIN 1006E

$491K

Aug 30, 2026

75A50126F61020

TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIOR…

$493K

Oct 29, 2026

15F06724F0001366

GSK TRAVEL VACCINES

$115K

Dec 31, 2026

75A50124F61014

THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL …

$18.4M

Feb 21, 2027

75A50124F61013

THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) …

$15.4M

Feb 21, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 15F06726F0000234?

15F06726F0000234 (GSK vaccines TERMS and conditions REMAIN) is a Division 1200 award with a potential value of $105K, currently held by Glaxosmithkline LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15F06726F0000234?

Division 1200 awarded 15F06726F0000234 to Glaxosmithkline LLC (potential $105K).

Who is the incumbent on 15F06726F0000234?

Glaxosmithkline LLC is the incumbent with $3.0B across 194 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.

When does Glaxosmithkline LLC’s 15F06726F0000234 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 14, 2026